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Preparing Tomorrow’s Clinicians through Fellowships 
in Health Policy 
__________________________________________ 
 
As an academic medical center, Thomas Jefferson University Hospital (TJUH) is 
charged not only with providing quality healthcare to its patients but also with 
preparing new clinicians to be ready for tomorrow’s healthcare industry. Part of the 
challenge of readying future healthcare providers for the road that lies ahead is the 
quick and constant shifting of the healthcare landscape. On one horizon, the future is 
bright with potential: there is an abundance of new medical developments, an 
explosion of health information sources (i.e., the Internet), a wealth of innovative 
software solutions for health system integration, and a national focus on quality 
improvement. However, several blights on the healthcare landscape are shadowing 
the progress that has been made: medical errors are in the news and on the rise1,
expenditures are escalating exponentially, and there is a growing uninsured 
population2. How is a young clinician to manage the unpredictable evolution of 
healthcare?  And from the TJUH perspective, how can established Jefferson Health 
System clinicians and practice groups who have survived tumultuous changes of the 
past two decades help prepare their younger colleagues to navigate these sometimes 
rough waters? At the Office of Health Policy and Clinical Outcomes (OHP), one 
attempt to educate health policy newcomers is a unique set of fellowship 
opportunities geared toward shaping tomorrow’s doctors, pharmacists, and other 
healthcare providers.   
 
One such opportunity, the Aetna US Healthcare Fellowship at OHP, is designed to 
develop physicians that are capable of responding to the ever-changing demands of 
the healthcare industry. For the young physician, the year affords many professional 
opportunities: 
 
• Career experience with physician leaders throughout the country; 
 
• Educational opportunities with directors of one of the largest HMOs in the 
world; 
 
• Attendance at the monthly Office of Health Policy conference, which attracts 
healthcare leaders from across the region; 
 
• Project management experience designing and implementing collaborative 
outcomes studies; 
 
• Didactic graduate work in epidemiology, biostatistics, clinical trials, and 
healthcare finances; and 
 
• The chance to work and learn under the direction of one of the nation’s top 
teams in health policy. 
 
David B. Nash, MD, MBA, Associate Dean and Director of OHP, believes that these 
myriad educational experiences provide new physicians with the tools to wrestle with 
the tough issues in healthcare today. 
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Similarly, OHP offers several opportunities for pharmacists (and other providers), 
which are somewhat divergent from traditional pharmacy practice, but forward-
minded in terms of healthcare. With U.S. health expenditures at $1.1 trillion dollars 
in 1997 and projected to double by 2008,3 the industry continues to seek ways to 
control these costs while preserving quality of care. Specially trained clinicians 
(physicians, pharmacists, nurses, etc.) can help healthcare leaders make policy 
decisions by investigating which pharmaceutical treatments, services, and products 
provide the best outcomes and offer the most cost-effective care. With the support 
of several major pharmaceutical companies (Knoll Pharmaceutical Company, 
SmithKline Beecham, and Janssen Pharmaceutica), the Office has co-sponsored 
fellowships in health economics and outcomes research since 1995. To date, all of 
the outcomes research fellows have had a pharmacy background; however, the 
fellowships are open to other healthcare providers also. 
 
The definition of outcomes research (OR) is two-fold: 
 
• the collection and analysis of data to determine value of health care products, 
procedures, services and programs, and 
 
• the evaluation of the clinical, economic, quality of life, and patient satisfaction 
outcomes of care.4
Because OR contributes to improved quality and cost effectiveness in healthcare, 
individuals with OR experience are in greater demand than ever before. Post-
graduate fellowship programs in OR have been developed across the country to train 
pharmacists and other clinicians to incorporate OR skills in various healthcare 
settings. 
 
The two-year fellowships offered at OHP help clinicians to establish a foundation of 
academic and practical experiences focused on economic, clinical, and humanistic 
principles of OR.  The first year is spent at the OHP where fellows are educated in 
research design, biostatistics, clinical economics, and health related quality of life 
principles through didactic coursework and research projects. The second year is 
spent at the sponsoring firm where fellows receive practical experience in outcomes 
research studies conducted in the pharmaceutical industry. 
 
OHP trained fellows are prepared to continue their careers in OR in a variety of roles 
and settings: as strategic planners, product managers, or directors in the 
pharmaceutical industry; as formulary managers or consultants for managed health 
care organizations; and as researchers, professors, or project directors in academia. 
The four current fellows agree that one of the most valuable experiences offered by 
the OHP fellowships is the chance to do “hands-on” research in a professional setting 
with experts in industry and academia. The partnerships between OHP and the 
pharmaceutical companies bridge the gap between “theory” (education/training) and 
“practice” (professional work). For the fellows, this broad-based, practical approach 
exceeds fellowships that are primarily didactic.   
 
For those interested in more information about OR fellowships nationwide, OHP has 
prepared a list of currently available health economic and outcomes research 
fellowships in the U.S. for the International Society for Pharmacoeconomics and 
Outcomes Research (ISPOR). Please visit the ISPOR website for more information 
about these fellowship opportunities at www.ispor.org. For specific information 
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